Our studies suggest that the ability of tumor cells to upregulate PD-L1 expression in response to IFN-γ stimulation may serve as a predictive marker for ICI responses (18), consistent with prior findings that IFN-γ and expanded immune gene signatures correlated with better ICI response in HNSCCs (75). The gene discussed is IFNG; the disease is neoplasm.